secwatch.observer — SEC 8-K summary
======================================

Issuer:     VitaNova Life Sciences Corp (VNOV)
CIK:        0001699709
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001683168-23-006408
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Yijia Group founder/CEO Xianchang Ma dies; heir gets 86.3% control; new CEO appointed
--------------------------------------------------------------------------------

- Founder and sole director Xianchang Ma passed away on August 3, 2023.
- On Sept 12, 2023, heir Caihong Qu acquired 5,066,250 shares (86.3% of outstanding) at $0 consideration, gaining control.
- Effective Sept 13, 2023, board comprises Qiuping Lu and Ruiming Zhou; Lu appointed CEO, President, and CFO.
- Ms. Lu previously served as CEO and CFO of China Herb Group Holdings from 2014 to 2019.
- Mr. Zhou has been a director at Shandong Tengjunxiang Biotechnology Co. since June 2017.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699709/000168316823006408/0001683168-23-006408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699709/000168316823006408/yijia_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-006408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer